Defining a cognitive function decrement in schizophrenia

被引:290
作者
Keefe, RSE [1 ]
Eesley, CE [1 ]
Poe, MP [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
关键词
schizophrenia; cognition; premorbid; parental education;
D O I
10.1016/j.biopsych.2005.01.003
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Background: Although cognitive impairment is described as a core component of the characterization of schizophrenia, a sizable percentage of patients are classified as unimpaired by traditional definitions of impairment. The purpose of this study was to determine the percentage of patients with schizophrenia meeting criteria for a "cognitive function decrement" defined as a current level of cognitive function that falls below the level predicted by premorbid estimates. Methods: Linear regression analyses were performed on a healthy control population to determine a predicted composite cognitive score based on maternal education, paternal education, and reading score as indicators of premorbid intellectual function. The percentages of patients with current cognitive function above and below predicted values were calculated. Results: When the Wide Range Achievement Test-3 (WRAT-3) score and maternal education are both used to predict current cognitive performance, as expected, about half (42%) of control subjects fall below expectations. However, 98.1% of patients fall below expectations. Conclusions: When cognitive function decrement is defined as a failure to reach the expected level of cognitive functioning, almost all patients with schizophrenia meet this definition.
引用
收藏
页码:688 / 691
页数:4
相关论文
共 23 条
[1]
Cognitive remediation of working memory deficits: durability of training effects in severely impaired and less severely impaired schizophrenia [J].
Bell, M ;
Bryson, G ;
Wexler, BE .
ACTA PSYCHIATRICA SCANDINAVICA, 2003, 108 (02) :101-109
[2]
BRYSON GJ, 1993, PERCEPT MOTOR SKILL, V76, P305
[3]
BUCHANAN RW, IN PRESS SCHIZOPHR B
[4]
Davidson M, 1999, AM J PSYCHIAT, V156, P1328
[5]
Elvevåg B, 2000, CRIT REV NEUROBIOL, V14, P1
[6]
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia [J].
Friedman, JI ;
Adler, DN ;
Howanitz, E ;
Harvey, PD ;
Brenner, G ;
Temporini, H ;
White, L ;
Parrella, M ;
Davis, KL .
BIOLOGICAL PSYCHIATRY, 2002, 51 (05) :349-357
[7]
Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance [J].
Fuller, R ;
Nopoulos, P ;
Arndt, S ;
O'Leary, D ;
Ho, BC ;
Andreasen, NC .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (07) :1183-1189
[8]
Use of oral reading to estimate premorbid intellectual and neuropsychological functioning [J].
Gladsjo, JA ;
Heaton, RK ;
Palmer, BW ;
Taylor, MJ ;
Jeste, DV .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 1999, 5 (03) :247-254
[9]
GOLDBERG TE, 1990, ARCH GEN PSYCHIAT, V47, P1066
[10]
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment [J].
Harvey, PD ;
Keefe, RSE .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (02) :176-184